Novel Protein Inhibitor Shows Antitumor Activity in Patients with NHL
Vall d'Hebron Institute of Oncology
Monotherapy with new PRMT5 inhibitor well tolerated with low toxicity in adults with B cell non-Hodgkin lymphomas
Lymphoma
Initiating r/r Lymphoma Treatment in Women: During vs. After Gestation
American Society of Hematology
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers
Car-T Therapy Improves Outcomes for Patients with B-Cell Lymphoma
University of Chicago Medical Center
Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable